Search

We chatted with Alan Manstof about his path to launching Easyday Edibles. What began with a stove-top gummy experiment evolved into a brand defined by clean ingredients and a laid-back ethos. In this interview, Manstof reflects on building a cannabis edibles brand, why every gummy deserves to be beautiful, and how his “analog place” became a guiding philosophy for the business. Source < Back Crafting Calm in a Fast-Paced World: The Story Behind Easyday Edibles Jun 9, 2025 Editorial Staff Outlaw Report Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link We chatted with Alan Manstof about his unconventional path to launching Easyday Edibles. What began with a stove-top gummy experiment evolved—after decades of curiosity and a marketing bootcamp led by his son—into a brand defined by clean ingredients, visual flair, and a laid-back ethos. In this interview, Manstof reflects on the lessons learned from building a cannabis edibles brand in Washington, D.C., why every gummy deserves to be beautiful and how his “analog place” became a guiding philosophy for the business. Source < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

The guide discusses the importance of financial modeling and projections for success in the cannabis industry. It covers understanding different cannabis verticals, key operational metrics, industry-specific knowledge, and building robust financial models. It emphasizes scenario planning, adapting to regulatory changes, capital management, and avoiding common pitfalls. The guide also highlights the role of the CFO and the importance of strategic preparation for navigating the industry's uncertainties. < Back Cannabis Financial Modeling & Projections with Rescheduling Considerations Sep 5, 2024 Dope CFO Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link As the green rush continues, a sobering reality is setting in: for every Cannabis company that blooms, another wilts. The problem? Despite the industry's explosive growth, many businesses are operating on shaky financial ground. They're navigating this complex landscape without a map, relying on gut instinct rather than solid financial planning. It's a recipe for disaster, and we're seeing the consequences play out in real time with shuttered storefronts and failed ventures. But here's the truth: it doesn't have to be this way. Over the past decade, we've learned invaluable lessons about what it takes to succeed in this volatile market. The solution is clear, yet often overlooked: robust financial projections and a solid financial model. These aren't just fancy spreadsheets – they're the lifelines that allow companies to weather storms, pivot quickly when needed, and seize opportunities as they arise. As a CPA who's been in the Cannabis finance trenches for years, I've seen firsthand how proper financial planning can make the difference between thriving and barely surviving. With potential Schedule III rescheduling on the horizon, the stakes have never been higher. It's time to pull back the curtain on the financial strategies that separate the winners from the losers in this green gold rush. In this guide, I'm pulling back the curtain on one of the most crucial, yet often overlooked, aspects of Cannabis business success: financial modeling and projections. Whether you're a seasoned Cannabis CFO or an accountant looking to break into this exciting field, mastering these skills isn't just beneficial – it's essential. We'll dive deep into why understanding the nuances of Cannabis operations across different verticals is non-negotiable for creating accurate models. You'll learn why your financial projections need to be as adaptable as the industry itself, and how to prepare for various scenarios, including the game-changing potential of Cannabis rescheduling. The Foundations of Cannabis Financial Modeling To build a solid financial model for a Cannabis business, you need more than just accounting skills – you need a deep understanding of the industry's unique landscape. Let's start with understanding different Cannabis verticals. Understanding Different Cannabis Verticals The Cannabis industry isn't monolithic. Each vertical in the Cannabis industry operates under its own unique set of circumstances, costs, and revenue streams. A one-size-fits-all approach to financial modeling simply won't cut it. By understanding the intricacies of each vertical, you can create more accurate, tailored financial models that reflect the true nature of the business. Here are some basic considerations for each vertical that can affect financial projections: 1. *Cultivation:* Whether indoor, outdoor, or greenhouse, cultivators face unique challenges like crop cycles, yield variations, and the impact of weather or pests. 2. *Manufacturing:* This includes extraction, infusion, and product development. Key considerations here include equipment costs, R&D expenses, and regulatory compliance for product safety. 3. *Retail (Dispensaries):* These businesses deal with rapid inventory turnover, cash-handling challenges, and the need to stay on top of consumer trends. 4. *Vertically Integrated Operations:* Many Cannabis companies operate across multiple verticals, adding complexity to financial models. Not sure where to begin? Develop a comprehensive knowledge base for each vertical. This might involve shadowing operations, interviewing experts, or enrolling in specialized training programs. The goal is to speak the language of each vertical fluently, allowing you to create financial models that resonate with operators and investors alike. DOPE CFO offers a comprehensive program to help individuals attain their goals. Through this training, participants will learn the ins and outs of the operations for various Cannabis verticals, and how to provide critical, world-class CFO services. Enroll in the DOPE CFO program today and take the first step towards owning your very own Cannabis FO firm. Click here to get started! Key Operational Metrics for Each Vertical Each vertical has its own set of crucial metrics that need to be incorporated into your financial model. These metrics are the pulse of Cannabis operations. They provide critical insights into efficiency, profitability, and overall health of the business. Ignoring or misunderstanding these metrics can lead to flawed financial models that fail to capture the true performance of the company. Here’s a short list of metrics to get you started: 1. *Cultivation:* Yield per square foot Cost per gram produced Cultivation cycles per year 2. *Manufacturing:* Extraction efficiency Product development cycle time Cost per unit manufactured 3. *Retail:* Average transaction value Customer acquisition cost Inventory turnover rate 4. *Vertically Integrated:* Inter-company transfer pricing Overall profit margin across verticals Now that you have a short list of metrics, what next? Create a robust system for tracking and analyzing these metrics. This might involve implementing industry-specific software solutions or developing custom dashboards. The key is to have real-time access to these metrics, allowing you to update your financial models promptly and make informed decisions. The Importance of Cannabis Industry-Specific Knowledge The Cannabis industry is unlike any other. Its unique challenges and opportunities require a specialized approach to financial modeling. Without this industry-specific knowledge, your financial models risk being disconnected from reality, potentially leading to poor business decisions or skepticism from investors. Here are some crucial things that you need to know about the industry that will affect your financial models and projections. 1. *Regulatory Landscape:* Understanding state-specific regulations and how they impact operations is vital. For instance, some states have restrictions on vertical integration, affecting how you structure your financial model. 2. *Tax Implications:* Section 280E of the Internal Revenue Code significantly impacts Cannabis businesses, limiting deductions and inflating effective tax rates. Your financial model needs to account for its effects on taxable income and cash flow. However, with potential rescheduling to Schedule III on the horizon, models should also incorporate scenario planning for a post-280E world. This shift could dramatically alter tax liabilities, potentially increasing cash flow and profitability overnight. A robust financial model should be flexible enough to toggle between current 280E constraints and potential future scenarios where these restrictions are lifted, allowing businesses to visualize and prepare for this transformative change. 3. *Banking and Financing Challenges:* Limited access to traditional banking services affects how Cannabis businesses manage cash flow, a critical factor in financial modeling. Even with potential rescheduling to Schedule III, banking reform may still be necessary. According to recent reports, anti-money laundering statutes would still apply, meaning rescheduling alone might not significantly alter the risk profile for financial institutions serving Cannabis businesses. Your financial model should account for continued banking challenges and potential sudden changes if reform does occur. 4. *Rapid Market Changes:* The Cannabis market can shift quickly due to regulatory changes, new product trends, or supply fluctuations. With potential rescheduling to Schedule III, we could see a flood of new products entering the market, increased competition, and significant shifts in supply and demand dynamics. These changes could dramatically affect pricing and market share. Your financial model needs to be flexible enough to adapt to these potential seismic shifts, incorporating scenario planning for various outcomes, including rescheduling. 5. *Compliance Costs:* Adhering to state regulations and seed-to-sale tracking requirements adds significant costs that must be factored into your financial model. With rescheduling, there's potential for new federal compliance measures that could be costly. For instance, the FDA might introduce new quality control and testing requirements for Cannabis products. Your financial model should include provisions for increased compliance costs, potentially offsetting some of the tax benefits that rescheduling might bring. By deeply understanding these foundational elements, you'll be well-equipped to create financial models that truly reflect the realities of operating in the Cannabis industry. Remember, your financial model is only as good as your understanding of the industry itself, and your access to insights around changes in the landscape that directly or indirectly affect each vertical. As we move into the next section on building robust financial models, keep in mind that these foundational elements are the building blocks upon which all successful Cannabis financial models are built. Without this strong foundation, even the most sophisticated modeling techniques will fall short. Building Robust Financial Models for Cannabis Companies Forget everything you know about traditional financial models. In the Cannabis industry, your spreadsheets need to be as adaptable and resilient as the plant itself. One regulatory shift, one market disruption, and those carefully crafted projections can go up in smoke. But here's the real challenge: How do you create a financial roadmap when the terrain keeps shifting beneath your feet? With federal rescheduling on the horizon and state regulations in constant flux, yesterday's gold standard could be tomorrow's liability. This is where mastering Cannabis-specific financial modeling becomes your secret weapon. It's not just about crunching numbers—it's about crafting a dynamic tool that can pivot as quickly as the market itself. Let's dive into the essential components that will transform your financial model from a static spreadsheet into a powerful strategic asset. In this section, we're going to dive deep into what it takes to build a financial model that doesn't just survive in the Cannabis industry—it thrives. We'll explore the essential components that every Cannabis financial model must have, how to incorporate industry-specific factors that can make or break your projections and the role of cutting-edge technology in keeping your model sharp and relevant. Additionally, all financial models should be updated at least quarterly, even after the capital is raised so you can track your progress as well as make adjustments to market conditions. You also must have a method for allocating certain Operating Expenses, into Inventory and COGS each period. Essential Components of a Cannabis Financial Model Your financial model needs to capture all of the complexity of Cannabis compliance while remaining clear and actionable. It's not just about projecting numbers—it's about creating a financial narrative that can guide your business through the industry's inevitable twists and turns. Let's break down the critical components that will transform your financial model from a basic spreadsheet into a powerful strategic asset: 1. *Revenue Projections: * Product Mix Analysis: Break down revenue by product category (flower, edibles, concentrates, etc.). Each has different margins and growth trajectories. Pricing Strategy: Model various pricing scenarios, considering competition, quality positioning, and potential market saturation. Sales Channel Diversification: Project revenue across different channels (in-store, delivery, wholesale) as each has unique cost structures and growth potential. Market Share Assumptions: Base these on competitive analysis and market size projections. Seasonality and Trends: Factor in industry-specific trends like "Green Wednesday" before Thanksgiving or 4/20 sales spikes. Regulatory Impact: Model potential new revenue streams from rescheduling, like interstate commerce or new product categories. 2. *Cost of Goods Sold (COGS): * Direct Costs: Include cultivation costs (if applicable), procurement, labor, and materials. Also, all indirect costs must be accounted for via GAAP-level cost accounting. Processing and Packaging: Factor in costs for extraction, infusion, packaging, and labeling. Testing and Compliance: Include costs for required lab testing and compliance with state regulations. Inventory Valuation: Use appropriate inventory valuation methods considering 280E implications. Economies of Scale: Model how COGS might decrease with increased production volumes. Supply Chain Disruptions: Include contingencies for potential supply chain issues. 3. *Operating Expenses:* Salaries and Wages: Break out by department, including budtenders, grow staff, management, etc. Marketing and Advertising: Factor in restrictions on Cannabis advertising and alternative marketing strategies. Rent and Utilities: These can be significant, especially for cultivation operations. Security: A major expense in this cash-heavy, high-value product industry. Professional Services: Legal, accounting, and consulting fees are often higher in Cannabis. Banking and Financial Services: Include higher fees associated with Cannabis banking. Compliance Costs: Factor in costs for seed-to-sale tracking, regulatory reporting, and potential federal oversight post-rescheduling. 4. *Capital Expenditures:* Initial Setup Costs: For new operations, include costs for buildout, equipment, and licensing. Ongoing CapEx: Factor in regular equipment upgrades and maintenance. Expansion Plans: Model costs for new locations, increased production capacity, or vertical integration. Technology Investments: Include costs for POS systems, security, and other essential tech. Compliance CapEx: Budget for potential new equipment needed to meet evolving regulations. 5. *Cash Flow Projections:* Detailed Monthly Projections: Create a month-by-month cash flow forecast for at least 24 months as well as a five-year cash flow statement. Working Capital Needs: Model cash tied up in inventory and receivables. 280E Impact: Show how 280E affects cash flow by limiting deductions. Investing Activities: purchases of equipment, expansion, growth plans. Financing Activities: Include loan repayments, lease obligations, and potential equity investments. Scenario Analysis: Create best-case, worst-case, and most likely scenarios, including a post-rescheduling scenario without 280E. 6. *Regulatory and Compliance Modeling:* License Renewal Costs: Factor in the costs and timing of license renewals. Potential Fines: Include a contingency for potential regulatory fines. Policy Changes: Model the financial impact of potential changes in state or federal law. 7. *Tax Planning:* 280E Analysis: Model effective tax rates under 280E and create a separate scenario for post-rescheduling. State and Local Taxes: Include all applicable taxes, which can be substantial in Cannabis. Tax Efficiency Strategies: Model potential strategies for improving after-tax cash flow. Why This Matters: A comprehensive financial model that includes all these components provides more than just numbers—it offers a roadmap for navigating the complex Cannabis landscape. It allows for strategic decision-making, helps identify potential pitfalls before they occur, and provides a solid foundation for raising capital or planning exits. *Solution:* Develop a modular financial model that allows for easy updates and scenario analysis. Use industry benchmarks to sanity-check your assumptions. Most importantly, view your model as a living document—update it regularly as the industry evolves and your business grows. Additionally, all financial models need a summary tab (all key metrics and returns), a five-year P&L, a five-year Balance Sheet, a five-year Statement of Cash Flows, and an Assumption tab with all key assumptions listed, as well as “switches” that allow to toggle between and change various assumptions (ie. pricing) that will then flow through the model. Remember, in the Cannabis industry, your financial model is often your first line of defense against uncertainty and your best tool for capitalizing on opportunities. Make it robust, make it flexible, and above all, make it accurate. Incorporating Industry-Specific Factors Financial models that work for Fortune 500 companies crumble in the face of Cannabis industry realities. Why? Because they're built for stability, not seismic shifts. When a single line in the tax code can slash your profitability overnight, or a regulatory change can open up entirely new markets, you need more than just numbers in cells. What you need is a financial model that's part crystal ball, part Swiss Army knife. One that doesn't just track where you've been, but helps you navigate where you're going—even when the destination keeps changing. So, let's roll up our sleeves and dive into the critical industry-specific factors that will transform your financial model from a mere spreadsheet into a strategic powerhouse: 1. *280E Tax Implications and Rescheduling:* Current 280E Impact: Model the precise impact of 280E on your effective tax rate, separating COGS from non-deductible expenses. Rescheduling Scenarios: Create detailed projections for a post-280E world, including: – Immediate tax savings and cash flow improvements – Potential for retroactive tax relief – How tax savings might be reinvested in business growth or R&D Transition Period Modeling: Account for a potential transition period where 280E may be phased out gradually rather than immediately. State-Level Considerations: While the impact of federal rescheduling on state-level Cannabis taxes is not yet known, it's important to model various scenarios. Your financial model should be flexible enough to accommodate potential shifts in state-level policies. Consider creating multiple projections based on: – States maintaining their current tax structures – Potential adjustments states might make in response to federal changes – The possibility of new state-level taxes or fees New Federal Taxes: Model potential new federal excise taxes that could be introduced post-rescheduling. International Tax Implications: For businesses with global aspirations, consider how rescheduling might affect international tax treaties and global operations. 2. *Regulatory Compliance Costs in a Rescheduled Landscape:* Current Compliance Costs: Break down all current compliance costs, including licensing, testing, reporting, and seed-to-sale tracking. FDA Oversight Preparation: Model potential costs for complying with FDA regulations, including: – Good Manufacturing Practices (GMP) implementation – Clinical trials for medical claims – New product approval processes Interstate Commerce Compliance: Factor in costs for complying with potential interstate commerce regulations, including new licensing and reporting requirements. Federal Agency Inspections: Budget for more frequent inspections from federal agencies like the FDA, USDA, or EPA. Product Standardization Costs: Include expenses for potential required changes in product formulations, packaging, or labeling to meet federal standards. Expanded Testing Requirements: Model increased costs for more comprehensive product testing that may be required under federal oversight. Legal and Consulting Expenses: Increased budget for legal and consulting fees to navigate the transition to federal regulation. 3. *Banking and Financial Services Post-Rescheduling:* Current Banking Challenges: Model current high fees, limited services, and costs of cash management. Gradual Banking Normalization: Create a staged model for how banking relationships might evolve post-rescheduling: – Initial period: Some banks are still hesitant and fees remain high – Medium-term: More banks enter the market, fees begin to decrease – Long-term: Full normalization of banking relationships Traditional Financial Services Access: Model the financial impact of gaining access to: – Business loans at standard interest rates – Credit card processing with normal fees – Investment and wealth management services Capital Markets Access: Project the potential for listing on major stock exchanges and accessing institutional investors. Insurance Cost Reductions: Model potential decreases in insurance premiums as the industry becomes federally legal. International Banking: Consider how rescheduling might open up international banking opportunities for expansion. 4. *Market Dynamics Post-Rescheduling:* Industry Consolidation: Model scenarios for increased M&A activity and how it might affect your market position. New Competitor Entry: Project how big pharma, alcohol, or tobacco companies entering the market might impact pricing and market share. Product Innovation: Budget for increased R&D to compete in a potentially more crowded market. Market Expansion: Model potential new market opportunities that could open up post-rescheduling (e.g., federal contracts, mainstream retail channels). 5. *Operational Changes with Rescheduling:* Supply Chain Optimization: Model cost savings from potential interstate commerce allowances. Workforce Development: Budget for potential new hiring needs to meet federal compliance standards. Capital Expenditures: Project investments needed to upgrade facilities to meet potential new federal standards. By incorporating rescheduling considerations into your financial model, you'll be better prepared to navigate the significant changes that could come with Cannabis rescheduling. This forward-thinking approach allows you to not just react to changes, but to strategically position your business to capitalize on new opportunities in a rescheduled Cannabis landscape. The Art of Cannabis Business Projections Projections in the Cannabis industry often amount to little more than wishful thinking. CEOs paint rosy pictures of exponential growth, while investors nod along, both ignoring the industry's notoriously unpredictable nature. The result? Businesses that crash and burn when reality fails to meet their inflated expectations. But here's the real danger: with potential rescheduling on the horizon, even seasoned Cannabis entrepreneurs find themselves in uncharted waters. How do you project growth in a market that could transform overnight? How do you plan for a future where your biggest competitor might suddenly be Big Pharma? The solution lies in mastering the art of strategic projection. It's not about predicting the future with pinpoint accuracy—it's about preparing your business for multiple possible futures. Let's break down how to create projections that aren't just numbers on a page, but powerful tools for navigating the Cannabis industry's uncertain landscape: Short-term vs. Long-term Projections Balancing short-term realities with long-term potential is a delicate art. Here's what you need in order to create projections that serve both immediate needs and future aspirations: *Immediate Impact Modeling:* - Create detailed month-by-month projections for the next 12-24 months - Focus on cash flow, operational metrics, and immediate regulatory impacts - Include sensitivity analysis for key variables like pricing, demand, and compliance costs - Regularly update these projections with actual data, adjusting future months accordingly *Adaptive Long-term Forecasting:* - Develop flexible 3 to 5-year projections that can quickly adjust to regulatory changes - Include multiple scenarios based on potential rescheduling outcomes - Factor in industry trends like consolidation, new product categories, and evolving consumer preferences - Use rolling forecasts that are updated quarterly to reflect the latest market conditions *Milestone-based Projections:* - Tie long-term projections to specific industry or company milestones rather than fixed time periods - Include projections for key events like new market entries, product launches, or expansion phases - Create contingency plans for delays in reaching milestones, especially those dependent on regulatory changes Scenario Planning Relying on a single set of projections in the Cannabis industry is like navigating a minefield with a blindfold on. One unexpected regulatory change, one new competitor entering the market, and your carefully crafted plans crumble. Worse yet, with rescheduling on the horizon, the entire landscape could shift dramatically, rendering traditional forecasts obsolete overnight. But there's a way to turn this uncertainty into a strategic advantage. By mastering the art of scenario planning, you can prepare your business not just for one future, but for any future. Here's how to create a robust set of projections that can weather any storm: *Best Case Scenario:* - Model aggressive growth assuming favorable regulatory changes - Project rapid market expansion, potentially including interstate or international sales - Factor in the successful execution of your business strategy and product innovations - Include potential partnerships or M&A activities that could accelerate growth *Expected Case Scenario:* - Create a balanced projection based on current trends and moderate regulatory progress - Include gradual improvements in banking access and tax situations - Project steady but realistic market growth and increasing competition - Factor in ongoing compliance costs and potential new regulatory requirements *Worst Case Scenario:* - Plan for potential setbacks, including delayed rescheduling or unfavorable regulatory changes - Model for increased competition, including entry of large corporations post-rescheduling - Project market saturation in key segments and potential price compression - Include contingencies for unexpected compliance costs or legal challenges *Rescheduling Specific Scenarios:* - Develop projections for various outcomes of potential rescheduling - Model changes to taxation, including the potential end of 280E restrictions - Project the impact of possible interstate commerce on your supply chain and market reach - Analyze the potential entry of new competitors, including pharmaceutical and alcohol companies *DOPE CFO: Your Blueprint for Cannabis Financial Mastery* Navigate the complexities of Cannabis finance with confidence. The DOPE CFO program equips you with: • Cutting-edge financial modeling tools tailored for Cannabis businesses • Scenario planning techniques to prepare for regulatory shifts, including potential rescheduling • Expert guidance on 280E, GAAP optimization, and industry-specific accounting methods • Strategies to build a thriving CFO firm in just 6 months Don't let uncertainty derail your Cannabis business. Master the art of financial forecasting and scenario planning with DOPE CFO. Ready to elevate your Cannabis accounting practice? Click here to join DOPE CFO and transform uncertainty into opportunity! Adapting Projections to Regulatory Changes Yesterday's compliance gold standard could be tomorrow's legal liability. Cannabis entrepreneurs often find themselves scrambling to update projections and operations every time a new regulation drops (or not at all). With potential federal rescheduling looming, the stakes have never been higher. How do you plan for a future when the rules of the game could change at any moment? The key lies in building adaptability into the very core of your projections. Creating a flexible framework can turn regulatory volatility from a threat into a strategic advantage. Here's what your projections need so that your teams don't just react to change, but anticipate and capitalize on it: *Regulatory Trigger Points:* - Identify key regulatory changes that would significantly impact your projections - Create pre-planned adjustment strategies for each major potential change - Include both federal changes (like rescheduling) and state-level policy shifts - Develop a system for quickly disseminating regulatory updates throughout your organization *Compliance Cost Forecasting:* - Project how compliance costs might evolve under different regulatory scenarios - Factor in potential new federal oversight costs post-rescheduling - Include projections for upgrading systems and processes to meet new compliance standards - Model the financial impact of potential new testing or quality control requirements *Market Expansion Modeling:* - Create projections for potential new market opportunities that could open up with regulatory changes - Model the impact of possible interstate sales on your distribution and production strategies - Project costs and revenues associated with entering new state markets as regulations allow - Analyze potential mainstream retail partnerships and their impact on sales and brand positioning By approaching projections with this level of depth and flexibility, you're not just planning for a single future—you're preparing your business to thrive in any future. The CFO's Role in Capital Management Picture this: A Cannabis startup flush with investor cash, burning through millions on expansion, only to find themselves stranded in a cash desert when the market shifts (ie. Tilray, MedMen, etc).. Or worse, an established company caught flat-footed when rescheduling opens up new opportunities, but they lack the capital to seize them. These aren't hypothetical scenarios—they're cautionary tales played out across the industry. In the high-stakes world of Cannabis finance, capital isn't just king—it's the difference between thriving and barely surviving. But with regulations in flux and market conditions changing at breakneck speed, how do you ensure you're not just managing capital, but strategically positioning it for both defense and offense? This is where a skilled CFO becomes the linchpin of Cannabis business success. Let's break down the critical aspects of capital management in this dynamic industry: Ensuring Adequate Capitalization In the Cannabis world, running out of capital isn't just a setback—it's often a death sentence. With traditional financing options limited and investors growing increasingly savvy, there's little room for financial missteps. But here's the good news: with the right strategies, you can turn capital management from a constant worry into a strategic advantage. Let's dive into the key strategies that will keep your capital flowing, even in the face of regulatory upheavals and market shifts: *Cash Runway Analysis:* - Develop detailed cash burn rate projections - Create early warning systems for potential cash crunches - Model cash needs under various regulatory scenarios, including rescheduling *Strategic Reserve Planning:* - Establish and maintain cash reserves for unexpected regulatory changes or market shifts - Create contingency funds for potential compliance upgrades or legal challenges - Plan for opportunistic capital deployment in case of market disruptions *Capital Structure Optimization:* - Balance debt and equity to maximize flexibility and minimize the cost of capital - Consider alternative financing options unique to the Cannabis industry - Plan for potential changes in capital access post-rescheduling Creating and Maintaining a Rolling Cash Forecast Imagine steering a ship through fog, relying on a map drawn last year. That's essentially what many Cannabis businesses do with static cash forecasts. The consequences of flying blind? Missed opportunities, cash crunches, and in worst-case scenarios, business failure. With potential rescheduling on the horizon, the stakes have never been higher. How do you plan for a future that could change dramatically at any moment? The answer lies in dynamic, rolling cash forecasts. Here’s an overview of what we teach in our program about what is critically important in a rolling cash forecast: *Dynamic Forecasting Models:* - Implement 6 to 9-month rolling cash forecasts, updated weekly - Integrate real-time sales data and inventory metrics - Factor in seasonal fluctuations and regulatory payment schedules *Scenario-Based Cash Projections:* - Model cash flows under various regulatory outcomes - Create best-case, worst-case, and most-likely scenarios - Regularly stress-test forecasts against market volatility *KPI-Driven Cash Management:* - Identify and track cash conversion cycle metrics - Set trigger points for capital raising or cost-cutting measures - Align cash management strategies with overall business KPIs Strategies for Capital Allocation Across Different Scenarios Capital isn't just king—it's the kingmaker. But here's the rub: having money and knowing how to deploy it are two very different games. Many green rush entrepreneurs find themselves cash-rich after initial funding rounds, only to watch helplessly as opportunities slip through their fingers due to misallocated resources. The stakes? Missed market openings, stalled growth, and in the worst cases, business failure. So, how do you allocate funds when the ground beneath your feet could change at any moment? This is where strategic capital allocation becomes your ace in the hole. It's not about having the biggest war chest—it's about deploying your resources with surgical precision. Embrace scenario-based capital allocation, to ensure that your company’s funds will last regardless of what happens. Here’s what you need to consider: *Regulatory-Responsive Investing:* - Create capital allocation strategies for different regulatory outcomes - Plan for potential fast-track expansions if interstate commerce opens up - Reserve capital for compliance upgrades in case of increased federal oversight *Market Opportunity Funds:* - Set aside capital for rapid deployment into emerging opportunities - Create decision matrices for evaluating and acting on time-sensitive investments - Develop partnerships or M&A strategies backed by earmarked funds *Risk Mitigation Reserves:* - Allocate capital for potential legal challenges or regulatory fines - Create insurance reserves for gaps in available coverage - Plan for potential tax liabilities, especially in light of 280E uncertainties Strategic capital management elevates CFOs from number-crunchers to visionary leaders. In this green gold rush, victory doesn't go to those with the deepest pockets, but to those who wield their resources with precision and foresight. The true winners are the companies that turn every dollar into a lever for growth, regardless of regulatory curveballs or market shifts. Common Pitfalls in Cannabis Financial Modeling and How to Avoid Them The Cannabis industry's graveyard is littered with the remains of once-promising companies, their demise often traced back to a single root cause: flawed financial modeling. From overenthusiastic revenue projections to underestimated compliance costs, these miscalculations can turn today's green rush into tomorrow's cash crunch. But here's the real tragedy: many of these failures were entirely preventable. With potential rescheduling on the horizon and market dynamics in constant flux, the margin for error in financial modeling has never been slimmer. How can you ensure your financial models aren't built on a foundation of sand? The key lies in recognizing and actively avoiding the most common pitfalls. Let's break down these dangers and arm you with strategies to safeguard your financial future. Overestimating Market Size or Growth Rate Inflated market projections: the silent killer of Cannabis startups. It's tempting to see dollar signs in every potential customer, but this rosy outlook often leads to overextended operations and drained capital. With rescheduling on the horizon, realistic market assessment is more crucial than ever. The antidote? Hard data and conservative projections. Here's how to keep your growth estimates grounded in reality: *Reality-Based Market Analysis:* - Utilize third-party market research to validate growth assumptions - Factor in potential market saturation, especially in mature Cannabis markets - Consider the impact of black market competition on addressable market size *Conservative Growth Modeling:* - Use stepped growth projections rather than smooth curves - Model the impact of potential new entrants, especially post-rescheduling - Include scenario planning for market contractions or regulatory setbacks Underestimating Capital Needs Startup funds vanish fast in this industry, often leaving promising ventures high and dry. It's not the planned expenses that sink ships—it's the hidden icebergs of unexpected costs, regulatory hurdles, and tax burdens. Smart operators plan for the unplannable. Here's what to include to help bulletproof your financial strategy: *Comprehensive Capital Planning:* - Include often-overlooked costs like license renewals and ongoing compliance - Factor in the cash flow impact of 280E on tax liabilities - Build in buffers for unexpected regulatory changes or legal challenges *Scenario-Based Capital Modeling:* - Create capital need projections for best-case, worst-case, and likely scenarios - Model the impact of potential rescheduling on capital requirements - Plan for stepped capital raises rather than relying on a single round Compliance: The Hidden Profit Killer Most Cannabis entrepreneurs look at sales projections the wrong way and often miss the fine print of compliance that determines whether those dollars ever reach the bottom line. Underestimate these costs, and you might find your profit margins vanishing faster than smoke in the wind. Pay attention to these important compliance considerations: *Detailed Compliance Budgeting:* - Break down compliance costs by category: licensing, testing, reporting, etc. - Include ongoing training and auditing expenses - Factor in potential costs of upgrading to new compliance standards post-rescheduling *Compliance Cost Scaling:* - Model how compliance costs change with business growth - Include scenario planning for new compliance requirements - Budget for potential interstate compliance needs if rescheduling allows expansion Success in this industry doesn't hinge on perfect predictions but on strategic preparation. The most effective financial models anticipate various outcomes and adapt quickly to change. By consistently refining your approach based on new data and regulatory shifts, you position your business to thrive amidst uncertainty. Looking Ahead As the Cannabis industry continues to mature and potentially undergoes significant regulatory changes, the role of financial professionals will only grow in importance. Those who can navigate the complexities of Cannabis finance while maintaining flexibility and foresight will be invaluable assets to their organizations. The future of Cannabis finance is bright for those willing to embrace its challenges and respect the importance of processes and planning as a means toward predictable profit. If you’re an investor or business owner looking to prepare for what's next in the industry and ensure that your business is properly positioned for growth, our DOPE CFO Certified Advisors are here to help! If you’re an accounting professional looking to help Cannabis CEOs with their financial modeling and planning, consider joining our nationally recognized Cannabis accounting program where you will learn the ins and outs of providing world-class, high-level, CFO services (like preparing projections and financial models). < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

The cannabis tourism market is growing, but Colorado has seen a decline in cannabis spending. Dispensaries near airports are wondering if they should invest in advertising to tourists, but a survey shows that airport proximity is not a major factor for travelers choosing a dispensary. Most travelers search for "dispensary near me," making local SEO more important than airport ads. Businesses should prioritize optimizing their Google Business Profile, collecting reviews, building mentions, creating local landing pages, and optimizing for AI search. Locals are a better investment for marketing budgets, as they provide higher long-term value and word-of-mouth marketing. < Back Dispensary Marketing in 2025: Google, AI, and Local Search Sep 8, 2025 Tyler Jacobson MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link How Dispensaries Can Win with Local SEO and Tourist Search Trends According to Grand View Research, cannabis tourism generated approximately $10.23 billion in 2023. Grand View analysts project the sector will hit $23.73 billion by 2030. While optimistic forecasts are welcome, those of us working in this tightly regulated industry have good reason to doubt the United States market will experience such rapid growth. Take Colorado, for example. Despite being a mature adult-use market, the state’s Department of Revenue has reported year-over-year declines in cannabis spending since 2021. In 2024, sales reached their lowest point since 2018. There’s no singular cause for the drop, but the novelty of visiting Colorado for a legal high may have worn off. With twenty-four states offering legal adult use and others enabling thriving hemp-derived THC markets, there’s less incentive to travel. If a similar experience is available nearby, why fly? Ironically, this decline has led many dispensaries, especially those near airports, to ask whether they should invest in outbound digital advertising aimed at incoming tourists. While the logic is understandable, my agency wanted to know if the idea had legs or was just wishful thinking. So, we conducted a consumer survey to find out. Advertising to tourists at the airport is a form of awareness play. The idea: A visitor lands, opens their phone, sees your ad, and either places an order or remembers your brand later when searching for a dispensary. There’s a catch, though: One impression is rarely enough. [image: Canna-tourism growth vs. Colorado decline and traveler purchase habits] The tourist survey we conducted revealed 52.7 percent of traveling consumers bring their stash with them, while 47.3 percent buy at their destination. That’s nearly a fifty-fifty split, which is great news for dispensaries hoping to serve travelers, even if they’re not visiting for cannabis alone. But survey respondents ranked airport proximity dead last among the criteria they consider when searching for a dispensary while on the road. In addition, most out-of-towners don’t search by dispensary name. Instead, like locals, they search for “dispensary near me.” This means brand visibility in local search is far more impactful than a flashy banner ad at baggage claim. Whether you’re marketing to locals or tourists, your first priority should be making sure your business is optimized for search by focusing on your local audience. According to *Forbes*, acquiring a new customer can cost up to seven times more than retaining an existing one. That makes locals the better investment for most dispensary marketing budgets, especially considering most tourists who responded to our survey indicated dispensary recommendations from friends and locals were nearly as influential as product selection and price. Locals aren’t just your most valuable customers; they’re also your best marketers. Ultimately, how people find you matters more than who they are. Search catches people at the moment they’re ready to buy. In May 2024, a massive Google algorithm documentation leak gave search engine optimization (SEO) professionals an unprecedented look into how search rankings actually work. While SEO pros long had relied on inferences and clues, the leak confirmed many longstanding assumptions and uncovered some new priorities that matter a lot for dispensaries. One of the most important priorities the documentation revealed is the way Google Business Profiles (GBPs) influence the search algorithm. If you haven’t already claimed a profile for your business, do so immediately. Then optimize it. Dispensaries face stricter advertising limits than traditional businesses, but a GBP is one of the few places that doesn’t censor cannabis businesses. Better yet, all businesses—traditional and plant-centered alike—play by the same GBP rules. GBPs show up in local search results based on relevance, reviews, and proximity. Dispensaries must ensure they categorize themselves as a “cannabis store.” Otherwise, they risk not showing up in search results for terms like “dispensary near me.” GBPs also collect reviews, much like businesses represented on Yelp and other directories, and both review volume and positivity matter. Encourage customers to leave a review on your business’s profile. Google’s leaked docs also revealed something else: The search giant evaluates businesses as entities, and websites are only part of the whole. In addition to considering website traffic and reviews, Google looks at how businesses are talked about across the web and whether their website’s content indicates they are an authority in their field. Consequently, a good strategy for boosting your appearance in search engine results is to focus your content on what you sell and where you sell it. Every page should reinforce your identity as a cannabis retailer in a specific location. If your site includes a blog or educational content, draw a clear line from every topic back to cannabis products and purchasing. Another surprise: Conventional SEO wisdom leaned heavily on the value of backlinks, which are links from other respected sites to yours. It turns out Google now cares less about backlinks than it does about mentions. If authoritative industry publications or other relevant sites are talking about your business, that sends a strong authority signal. The most impactful signals are those with a clear cannabis context. This is one of the clearest takeaways from the leak: Positive mentions from relevant, trustworthy sources help establish your business as legitimate and successful in its sector. One way to gain mentions is through well-thought-out, meaningful public relations campaigns. Media citation campaigns are a foundational local SEO tactic. Another type of tried-and-true citation campaign involves submitting your dispensary’s details (name, address, phone number, hours, etc.) to reputable business directories and local listing services. Listing your business in multiple directories proves the operation is real and open to the public. Accuracy counts here, so police the listings every so often to ensure they remain up to date. Conflicting directory information can harm a dispensary’s Google visibility. Also ensure your website has a unique page for each physical dispensary location. Your homepage can’t be expected to rank for every local query. At our agency, we follow a simple philosophy: One page per keyword. That means if you want customers to find you when searching for a “dispensary near Capitol Hill,” your site should include a page dedicated to that specific location. If you operate a dispensary in Dupont Circle, for example, a page devoted to that dispensary might mention the distance to the Capitol complex along with hours of operation, products, and prices. Location pages can help you rank locally and create a better user experience. They allow dispensary chains to include detailed info about each store—directions, parking, product menus, events—so the customer doesn’t have to dig. Dispensary Marketing Priorities - ✔ Claim & optimize your *Google Business Profile* - ✔ Ensure correct category (*“Cannabis Store”*) - ✔ Collect and encourage *customer reviews* - ✔ Build *mentions* & local citations - ✔ Create dedicated *local landing pages* - ✔ Optimize for *AI search* In addition to traditional SEO strategies, businesses need to be aware of the emergence of search results augmented by artificial intelligence (AI). We are in the midst of a transition from traditional search to AI search. There are some complex technical considerations that AI favors in search results, but for the most part dispensaries should focus on ensuring these answer engines have enough information about and trust in your business to recommend it when consumers ask relevant questions. Dispensary marketing budgets often are limited, so make every dollar work smarter by boosting organic visibility. Start with a Google Business Profile. Optimize your site’s content. Build out citations by earning relevant mentions. And above all else, invest in strategies that build trust and visibility for the long term. Search optimization is a long game. Success won’t be an overnight accomplishment, but it will have lasting value once achieved. ------------------------------ Dispensary SEO and AI Search: Key Questions Answered Why is local SEO important for dispensaries? Local SEO ensures dispensaries appear in searches like “dispensary near me,” capturing consumers at the moment they’re ready to buy. How do Google Business Profiles impact dispensary marketing? GBPs influence rankings by relevance, reviews, and proximity, making them essential for cannabis retailers to claim and optimize. Should dispensaries focus more on locals or tourists? Locals provide higher long-term value and word-of-mouth marketing, while tourists are more opportunistic buyers. Do backlinks still matter for dispensary SEO? Backlinks are less important than authoritative mentions from cannabis-related media and directories. How is AI changing dispensary search results? AI-powered search engines prioritize businesses with strong profiles, accurate citations, and trusted mentions, making optimized content even more important. ------------------------------ [image: Tyler Jacobson Hybrid Marketing Co] *Based in Denver, Tyler Jacobson is director of marketing at Hybrid Marketing Co., a full-service creative agency serving highly regulated industries including cannabis and hemp. With more than twenty years of digital marketing experience, he specializes in turning visions into actionable outcomes by understanding customer needs, simplifying complexity, and aligning teams around shared goals.* < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

The provided text summarizes a "Marijuana Moment" newsletter from October 3, 2025. Key topics include California Governor Gavin Newsom's humorous remarks about national marijuana legalization and his signing of a bill to regulate intoxicating hemp products. Other news covers a Florida court ruling against vehicle searches based solely on cannabis smell, an Oregon lawsuit challenging the state's cannabis export ban, a New York hearing on psilocybin, and a survey indicating medical cannabis helps chronic pain. Federal updates include the White House classifying drug cartels as "nonstate armed groups" engaged in "armed conflict" with the U.S., and the DEA placing a cannabinoid receptor agonist in Schedule I. State and local news includes a Kansas court case on cannabis smell and police searches, Minnesota addressing medical cannabis business head starts, New Jersey regulators acting on licensing, Oregon accepting psilocybin services applications, and a New Hampshire board meeting. Internationally, Morocco signed medical cannabis agreements. Science and health sections mention studies on low-frequency cannabis use in older adults and cannabinoids reducing pruritus. Advocacy, opinion, and business news are also covered. < Back Newsom talks national cannabis legalization in Trump-mocking post (Newsletter: October 3, 2025) Oct 3, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *FL marijuana smell court ruling; OR interstate cannabis commerce lawsuit; NY psychedelics hearing; Survey: Medical marijuana helps chronic pain* Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: *Your support makes Marijuana Moment possible…* *Your good deed for the day:* donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment */ TOP THINGS TO KNOW* California Gov. Gavin Newsom (D) joked in another Trump-style social media post that he will be legalizing marijuana nationwide under the new role of “leader of the free world” he’s proclaiming in light of the federal government shutdown—saying that people will be “high on patriotism.” California Gov. Gavin Newsom (D) signed a bill to integrate intoxicating hemp products into the state’s existing marijuana market—saying that “for too long, nefarious hemp manufacturers have been exploiting loopholes to make their intoxicating products easily available to our most vulnerable communities.” The Florida Second District Court of Appeal ruled that police cannot search a person’s vehicle based only on the smell of cannabis—determining that the legalization of medical marijuana and hemp have “fundamentally changed” the plant’s “definition and regulation.” An Oregon marijuana business filed a federal lawsuit seeking to overturn the state’s ban on cannabis exports and imports to and from other states—arguing that prohibiting interstate commerce violates the U.S. Constitution’s Dormant Commerce Clause. The New York Assembly Health Committee held a hearing on psilocybin—taking testimony about the therapeutic potential of the psychedelic from medical professionals, researchers, patients and advocates. A new survey shows that 86 percent of patients say medical cannabis improved their chronic pain moderately or significantly—and that using marijuana helped to completely eliminate the use of prescription drugs for one in three patients. Michigan House Speaker Matt Hall (R) is threatening to walk away from budget negotiations and effectively shut down the state government if the Senate doesn’t agree to a marijuana tax increase. The Kansas Bureau of Investigation launched raids against retailers engaging in “brazen” sales of cannabis and THC products in six cities across the state. */ FEDERAL* The White House sent Congress a notification that President Donald Trump has determined that drug cartels are “nonstate armed groups” whose actions “constitute an armed attack against the United States,” and the country is thus engaged in a formal “armed conflict” with them. The Drug Enforcement Administration is placing the cannabinoid type 1 receptor agonist MDMB-4en-PINACA in Schedule I, saying its pharmacological action is “similar to other schedule I cannabinoids, such as Δ9-tetrahydrocannabinol (Δ9-THC), which all have high abuse potential.” */ STATES* A Kansas Court of Appeals panel will hear a case about whether the smell of cannabis provides reasonable suspicion for police searches on October 14. A Minnesota regulatory spokesperson addressed concerns about medical cannabis businesses’ heads start on recreational marijuana sales. New Jersey regulators acted on marijuana business licensing and violation issues. Oregon regulators are accepting applications to serve on a psilocybin services rules advisory committee. The New Hampshire Therapeutic Cannabis Medical Oversight Board will meet on Wednesday. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* */ LOCAL* The Killeen, Texas City Council is considering authorizing more funding to defend the city’s voter-approved marijuana decriminalization law from lawsuit filed by Bell County. The La Crosse County, Wisconsin Board chair discussed a proposal to reduce the fine for marijuana possession to $1. */ INTERNATIONAL* Moroccan officials signed medical cannabis agreements with specialized medical associations. */ SCIENCE & HEALTH* A study found that “low-frequency cannabis use among older adults, including those along the dementia continuum, is generally well tolerated from a cognitive perspective.” A review concluded that “cannabinoids produced a modest but statistically significant reduction in pruritus, suggesting clinical relevance for symptom management.” */ ADVOCACY, OPINION & ANALYSIS* A Citizens for a Safe and Healthy Texas official authored an op-ed arguing that “if Republicans want to honor Charlie Kirk, they will stand up for a generation of young Americans being preyed on by the marijuana industry.” */ BUSINESS* Curaleaf Holdings, Inc.’s executive vice chairman established an automatic securities disposition plan. Herbarium owners are being sued for allegedly wrongfully terminating an employee who complained about unpaid overtime, stolen tips and other issues. Vertanical announced positive results from Phase 3 clinical studies of its standardized full-spectrum cannabis extract. Innovative Industrial Properties, Inc. closed its initial investment into IQHQ, Inc. *Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.* Get our daily newsletter. Email address: Leave this field empty if you're human: The post Newsom talks national cannabis legalization in Trump-mocking post (Newsletter: October 3, 2025) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

The partnership involves the distribution of Wana's hemp-based beverages and gummies. < Back JP Brand Advisors, Canopy USA Form Strategic Partnership to Expand Hemp Beverage Distribution Oct 7, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The partnership includes distributing Wana’s hemp-based beverages and gummies. < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

< Back Lemon Haze (Sativa) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) 4.8 169 Ratings average rating is 4.8 out of 5, based on 169 votes, Ratings $40.00 3.5g Order Now Description Lemon Haze is a premium Grade A sativa strain with 20.3% THC, featuring a citrus aroma. It provides energetic uplift, focus, and happiness, ideal for daytime creativity or mood boost. Effects energetic, focused, happy Previous Next Cheetah Piss (Sativa) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.8 172 Ratings average rating is 4.8 out of 5, based on 172 votes, Ratings Lemon Haze (Sativa) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.8 169 Ratings average rating is 4.8 out of 5, based on 169 votes, Ratings Forum Cookie (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.8 168 Ratings average rating is 4.8 out of 5, based on 168 votes, Ratings

Nebraska's Medical Cannabis Commission will cap cultivators at 1,250 flowering plants per license, as requested by Governor Jim Pillen, to prevent an unregulated black market supply. The commission plans to license four cultivators, with applications due by September 23 and licensing to begin by October 1. Initial proposals for plant limits were lower, but commissioners pushed for higher numbers to ensure sufficient supply for patients. The latest regulations, effective for 90 days if approved, would establish a "Recommending Health Care Practitioner Directory," make the program low-THC, and allow patients to purchase up to 5 ounces of medical cannabis in 30 days (with a 5-gram Delta-9 THC limit in 90 days). Twelve dispensaries would be permitted statewide, with prohibitions on smoking, vaping, and most edibles, though flavored oral tablets would be allowed. Currently, patients can legally possess cannabis with a recommendation, but no licenses have been issued for legal purchase within Nebraska. < Back Nebraska Governor Pushes Officials To Enact Medical Marijuana Cultivation Cap Sep 9, 2025 Marijuana Moment Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *“Leaving the cultivators without a limit would increase [the] likelihood of an overabundance of cannabis product that creates an unregulated, unintended black-market supply.”* *By Zach Wendling, Nebraska Examiner* The Nebraska Medical Cannabis Commission will cap cultivators for the new medicine to grow no more than 1,250 flowering plants at one time, adding a limit that the governor had requested. Gov. Jim Pillen (R), in a Thursday letter to the five-member commission, said while he appreciated commissioners’ work to “ensure the cannabis industry is properly regulated,” he would not sign new emergency regulations the commission approved September 2 without the group setting a limit on how many plants cannabis cultivators grow. “Leaving the cultivators without a limit would increase [the] likelihood of an overabundance of cannabis product that creates an unregulated, unintended black-market supply,” Pillen wrote. He continued: “If an inclusion of plant population limits for permitted cultivators can be included, I will support the remainder of the proposed emergency regulations to go into effect.” Last week, the commission said it would license only four medical cannabis cultivators. The first round of cultivator applications meeting the new regulations are due by September 23. Licensing must begin by October 1. Placeholder limits expanded The Medical Cannabis Commission built its discussion on top of a placeholder draft put forward by Bo Botelho, the general counsel for the Nebraska Department of Health and Human Services who is advising the commission pursuant to an inter-agency agreement. DHHS has opposed medical cannabis in the past, which is why advocates sought and ultimately won voter approval to house the new Medical Cannabis Commission elsewhere, that being the Nebraska Liquor Control Commission. Botelho said he worked backward from Missouri’s plant limits, noting the neighboring state grows plants for recreational and medicinal use. He proposed a much more stringent limit than allowed in the neighboring Show-Me State. He had proposed the following placeholder limits: - Indoor facilities: 200 flowering plants. - Outdoor facilities: 500 flowering plants. - Greenhouse facilities: 300 flowering plants. - A combination of the three types: 200 flowering plants. “The numbers that I came to isn’t the result of any real math,” Botelho said. “I just put some numbers in there to start with.” Commissioner Bruce Bailey of Lincoln led a push to increase the number of plants allowed. He noted some plants might be lost to crop failure while others might not meet new commission testing requirements. Bailey said he also wanted to be sure there was enough supply for Nebraska patients. Four of Nebraska’s six bordering states have legal medical cannabis programs, with the percentage of residents in those states using the programs as follows: Iowa, 0.55 percent; Colorado, 1.05 percent; South Dakota, 1.26 percent; and Missouri, 1.95 percent, according to the Marijuana Policy Project. Using a rough ratio of one plant serving every two patients, Bailey and other commissioners worked toward serving approximately 1 percent of the state, or a prospective 20,000 Nebraskans. Meeting patient demand Commissioner Lorelle Mueting of Gretna, an addiction prevention specialist with Heartland Family Service, said Nebraska also might not have 20,000 patients “right off the bat,” and joined with Commissioner Kim Lowe of Kearney, voicing an intent to review the numbers in the future. Mueting said that in the limited time between Pillen’s Thursday decision not to sign on and the commission’s “emergency” Monday meeting, she had researched that 2,000 indoor plants might be able to produce enough tinctures for 2,300 patients each year. “I don’t know how all this translates into plants, because, again…how much flower a plant can produce depends on how it’s grown, how it’s cultivated,” Mueting said. Rather than set specific limits for indoor, outdoor or greenhouse facilities, Bailey proposed the 1,250 plant limit, no matter the type of facility. That would mean that with a total of four cultivators, there could be 5,000 active plants at once with two harvests anticipated annually, meeting the 10,000 plant goal. Crista Eggers, executive director of Nebraskans for Medical Marijuana, the nonprofit that led the successful 2024 petition campaign, said the commission was going to “starve” a program before it could start. “On your hands will be the blood of the patients in the state,” she said. Lia Post of Springfield, who has complex regional pain syndrome, again urged the commission to see her and other Nebraskans as patients. “My illness doesn’t change at state lines,” Post said. “I guarantee you I’m going to use cannabis instead of opioids or benzodiazepines or sedatives or ketamine, and if the most offensive thing I can do is cuss at you or tell you what a bunch of idiots you are, freedom of speech has gone to hell in Nebraska.” The Medical Cannabis Commission is scheduled to meet next at 1 p.m. on September 30. What would the latest medical cannabis emergency regulations mean? If approved, the latest set of emergency medical cannabis regulations would replace an earlier set that would expire by September 28. The new set would be in effect for a new 90-day period. The latest regulations would establish a “Recommending Health Care Practitioner Directory” and also make Nebraska’s program essentially a low-THC variety. Under the regulations, patients or caregivers could purchase up to 5 ounces of medical cannabis in a 30-day period, which is about 142 grams. Of that, patients could purchase no more than 5 grams of delta-9 tetrahydrocannabinol (THC) from the same dispensary within a 90-day period. Delta-9 THC is the part of cannabis most associated with a “high.” The amended regulations would maintain a limit of up to 12 medical cannabis dispensaries statewide arranged by judicial district. That would mean one dispensary each in Douglas County (584,526 residents), Lancaster County (322,608 residents), Sarpy/Cass Counties (217,202 residents) and Buffalo/Hall Counties (112,979 residents), according to 2020 census data. The rules would still prohibit dispensaries from selling smoking or vaping products and edibles of any kind. While the earlier rules would have allowed the sale of non-sugarcoated gelatinous cubes, the revised rules would not. Oral tablets with a “thin layer” of flavoring to make the products swallowable would now be allowed. Under current law, a patient or qualified caregiver with a recommendation from any health care practitioner can legally possess up to 5 ounces of medical cannabis, in any form. But no licenses have yet been issued, so cannabis can’t legally be purchased in Nebraska yet. *This story was first published by Nebraska Examiner.* *Photo courtesy of Chris Wallis // Side Pocket Images.* The post Nebraska Governor Pushes Officials To Enact Medical Marijuana Cultivation Cap appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

Two cannabis industry leaders have partnered to introduce a new product line of hash rosin-infused edibles, offering a full-spectrum experience with a focus on flavor. < Back Grön, Head Change Debut Exclusive Solventless Edibles in Missouri Jun 18, 2025 Staff Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The two cannabis industry leaders collaborated to launch a new line of hash rosin-infused edibles for a flavor-forward, full-spectrum experience. < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

A coalition of 45 marijuana advocacy and medical groups is urging Congress to protect state medical cannabis programs and remove a provision that would bar the Justice Department from rescheduling cannabis. The article discusses the ongoing efforts to reform cannabis laws, including the stalled federal rescheduling process and support for reform from various public figures. < Back Major Health Groups Push Congress To Keep Protecting State Medical Marijuana Laws From Federal Interference Jul 16, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A coalition of 45 marijuana advocacy and medical groups—including Americans for Safe Access (ASA), U.S. Pain Foundation, National Multiple Sclerosis Society, Epilepsy Foundation of America and more—are calling on congressional lawmakers to ensure that state medical cannabis programs remain protected under spending legislation that’s advancing. Along with the letter sent to House and Senate appropriations leadership on Monday, ASA also noted that language currently in a House bill to continue existing protections for medical marijuana states against federal intervention omits Nebraska from the list of covered jurisdictions even though voters there legalized patient access to cannabis last year. ASA is also urging the removal of a separate section of the 2025 spending legislation that would bar the Justice Department from rescheduling cannabis. That provision was included in the House spending bill covering Commerce, Justice, Science, and Related Agencies (CJS) unveiled earlier this week that then advanced through subcommittee on Tuesday. The rider that protects state medical cannabis laws from federal interference, meanwhile, has been part of federal law since 2014 but requires renewal on an annual basis as part of appropriations legislation. “Medical cannabis patients are living with one or more medical conditions or experiencing symptoms for which cannabis or a cannabinoid-based product may be the only treatment option, a more suitable option, or work as an adjunct treatment, including side-effect mitigation from other medications in their treatment plans,” the signatories of the new coalition letter wrote. “Patients consistently report improved symptom relief, better daily functioning, and enhanced mental health with access to medical cannabis.” “Medical cannabis programs have become a lifeline for millions of Americans, including many of the 30 million Americans living with one of 7,000 known rare diseases (95 percent of which have no FDA-approved treatment available) as well as the one-third of Americans who live with chronic pain and the 10% of Americans living with debilitating, intractable pain. In fact, research generated from the state programs suggests medical cannabis may help some patients reduce or avoid certain high-risk medications, including opioids, contributing to lower rates of overdose and medication-related complications.” “Over the last decade, significant barriers to cannabis reform have been dismantled,” the letter continues. “Advocates have successfully championed regulatory changes enabling U.S.-based cannabis research, debunked outdated misconceptions in federal agencies, changed the scheduling of cannabis under United Nations treaties, established rigorous safety standards, and demonstrated clear medical benefits recognized by the [Food and Drug Administration].” “You have the power to protect the health, safety, and dignity of millions of Americans,” the letter concludes. “Until comprehensive, permanent federal legislation is enacted to align federal cannabis policy with state laws and integrate medical cannabis into mainstream healthcare, maintaining the Medical Cannabis CJS Amendment is essential.” Other signatories on the letter include the Tourette Association of America, Iraq and Afghanistan Veterans of America (IAVA), AIDS United and Minorities for Medical Marijuana. For the second time now, the base legislation contains language hostile to marijuana rescheduling efforts that remain ongoing. Specifically, the bill would block the Justice Department from using its funds to reschedule or deschedule marijuana. Under the Biden administration, DOJ recommended moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), but that process has been delayed for months amid challenges from witnesses in the administrative hearings. The language cleared committee as part of the last CJR spending bill, but it was not ultimately enacted into law. GOP senators have separately tried to block the administration from rescheduling cannabis as part of a standalone bill filed in 2023, but that proposal did not receive a hearing or vote. Meanwhile, the Drug Enforcement Administration (DEA) recently notified an agency judge that the marijuana rescheduling process remains stalled under the Trump administration. It’s been over six months since DEA Administrative Law Judge (ALJ) John Mulrooney temporarily paused hearings on a proposal to move cannabis to Schedule III. And in a joint report to the judge submitted earlier this month, DEA attorneys and rescheduling proponents said they’re still at an impasse. The longstanding medical cannabis rider as it appears in the new House spending bill contains a new addition stipulating that the Justice Department can still enforce a section of U.S. code that calls for increased penalties for distributing cannabis within 1,000 feet of an elementary school, vocational school, college, playground or public housing unit. That language was first included in the last version of the appropriations legislation. “The inclusion of the Medical Cannabis Amendment language is a partial victory for patients,” Steph Sherer, founder of Americans for Safe Access, said in a press release. “However, the changes to the amendment would put patients in harm’s way, and stopping the rescheduling process at this time would not only be a waste of taxpayers’ dollars, but also an unnecessary roadblock in getting to the truth about the medical uses of cannabis.” The CJS bill also keeps intact another longstanding rider preventing DOJ interference in state hemp research programs. Meanwhile, a retired professional football player who’s since become an advocate for marijuana policy reform met with top Trump administration officials at the White House last week to discuss the ongoing federal cannabis rescheduling process. U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. was previously vocal about his support for legalizing cannabis, as well as psychedelics therapy. But during his Senate confirmation process in February, he said that he would defer to DEA on marijuana rescheduling in his new role. Separately, former Rep. Matt Gaetz (R-FL) was reportedly photographed reviewing a document that appears to be a draft contract to provide services—including “administration-related guidance”—to a firm affiliated with the major marijuana company Trulieve. The visible portion of the document describes a lucrative bonus if a certain “matter resolves,” with an “additional ‘Super Success Fee’” for other “exclusive policy remedies.” Last month, the former congressman reiterated his own support for rescheduling cannabis—suggesting in an interview with a Florida Republican lawmaker that the GOP could win more of the youth vote by embracing marijuana reform. Gaetz also said last month that Trump’s endorsement of a Schedule III reclassification was essentially an attempt to shore up support among young voters rather than a sincere reflection of his personal views about cannabis. A survey conducted by a GOP pollster affiliated with Trump that was released in April found that a majority of Republicans back a variety of cannabis reforms, including rescheduling. And, notably, they’re even more supportive of allowing states to legalize marijuana without federal interference compared to the average voter. Meanwhile, Trump picked former Florida Attorney General Pam Bondi (R) to run DOJ, and the Senate confirmed that choice. During her confirmation hearings, Bondi declined to say how she planned to navigate key marijuana policy issues. And as state attorney general, she opposed efforts to legalize medical cannabis. Amid the stalled marijuana rescheduling process that’s carried over from the last presidential administration, congressional researchers recently reiterated that lawmakers could enact the reform themselves with “greater speed and flexibility” if they so choose, while potentially avoiding judicial challenges. Meanwhile, a newly formed coalition of professional athletes and entertainers, led by retired boxer Mike Tyson, sent a letter to Trump on Friday—thanking him for past clemency actions while emphasizing the opportunity he has to best former President Joe Biden by rescheduling marijuana, expanding pardons and freeing up banking services for licensed cannabis businesses. The post Major Health Groups Push Congress To Keep Protecting State Medical Marijuana Laws From Federal Interference appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

Stepping into MJBizCon is essential for making your mark in the cannabis industry. This post provides information for first-time attendees. < Back First time at MJBizCon? Here’s what you need to know. Jul 15, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Stepping into MJBizCon for the first time is exhilarating, overwhelming and essential for anyone who wants to make their mark in the cannabis industry. First time at MJBizCon? Here’s what you need to know. is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cookies & Alt Sol "Hollywood" Strain Review - Takoma Wellness Center As the name suggests, the Hollywood strain exudes the glitz and glamor of its namesake city. Grown by Alt Sol and now available at Takoma... Animal Face by RYTHM Strain Review (Maryland Recreational) Animal Face, cultivated by RYTHM, is a remarkable strain making its rounds at RISE dispensary in Silver Spring, Maryland. My awesome budt... Pink Passion - Goldflower, Largo (Florida Medical) At Goldflower Dispensary in Largo, Florida, this Pink Passion caught my eye for its understated elegance—medium spear-shaped buds in a deep purple shade, lightly threaded with orange hairs and coated in a moderate layer of clear trichomes that give it a subtle, sticky sheen. Grown indoors by DH Farms under Doghouse's banner, this hybrid clocks in at 23.6% total THC, hinting at a session that's engaging but not exhausting... 1 2 3 4 5

We've taken all the best Washington DC cannabis news sources and aggregated them into one simple feed. Now you can find stories about DC marijuana policy, laws, regulations, products, science, and more all in one place. Sort by Publication to find the cannabis news that's most important to you and your interests. Or, use our AI search to find ideal cannabis topics. DC Cannabis News ALL Washington DC Maryland Virginia Florida New York Filter by Publication Select Publication Filter by City Select City Filter by State Select State Oct 12, 2025 Outlaw Report Cultivation sales fall as D.C. medical cannabis market shows signs of slowdown D.C.'s medical cannabis sales fell to $8.2 million in August, a decrease from May's record, but still an 82% increase year-over-year. Vape and concentrate sales rose, while cultivation and manufacturing revenues dropped, indicating a potential market slowdown due to new federal oversight. City: Washington, D.C. State: Washington, D.C. Read More Oct 8, 2025 Outlaw Report D.C. Council passes bill extending conditional cannabis licenses The D.C. Council passed a bill extending conditional medical cannabis licenses by one year, giving operators more time to open due to real estate and financing delays. City: Washington, D.C. State: Washington, D.C. Read More Sep 17, 2025 Marijuana Moment Trump’s Marijuana Rescheduling Comments Are Making More Lawmakers Pay Attention To The Issue, Democratic Congresswoman Says As President Donald Trump continues to weigh a marijuana rescheduling proposal, a Democratic congresswoman says there’s been more discussion among lawmakers about cannabis reform recently–adding that she’ll “continue to push for” other modest policy changes such as industry banking access. City: NA State: Minnesota, Colorado, California, Washington, D.C. Read More Sep 10, 2025 MG Magazine House GOP Moves to Undermine Trump on Cannabis Rescheduling *WASHINGTON* – The House Appropriations Committee will vote September 10 on provisions in the fiscal year 2026 Commerce-Justice-Science (CJS) appropriations bill that would both strip rescheduling authority from the Trump administration and open the door to new Drug Enforcement Administration (DEA) crackdowns on state medical cannabis programs. City: NA State: Washington, D.C. Read More Jul 23, 2025 Outlaw Report Another D.C. psychedelic shop raided — and Congress advances bill to keep blocking D.C. rec weed This newsletter covers DMV cannabis news. City: Washington, D.C. State: Washington, D.C. Read More Jul 22, 2025 Marijuana Moment Congressional Subcommittee Votes To Keep Blocking... Congressional Subcommittee Votes To Keep Blocking Marijuana Sales In D.C. As Trump Requested In Budget City: Washington, D.C. State: Washington, D.C., Maryland Read More Jul 19, 2025 Outlaw Report D.C. closes third unlicensed psychedelic shop amid ongoing crackdown D.C. has shut down Bouquet Labs, an unlicensed cannabis grower, imposing a $10K fine and ordering a license sale after a raid found 999 illegal plants. City: Washington, D.C. State: Washington, D.C. Read More Jul 15, 2025 Outlaw Report D.C. Shuts Down Second Psychedelic Shop, Bouquet Labs Fined $10K, Virginia Eyes 2026 Cannabis Retail DMV cannabis news. Source Newsletter. City: Washington, D.C. State: Washington, D.C., Virginia Read More Jul 14, 2025 Outlaw Report Bouquet labs agrees to $10K fine & license sale after 999 illegal cannabis plants seized D.C. has shut down Bouquet Labs, an unlicensed cannabis grower, after a raid found 999 illegal plants. The company faces a $10,000 fine and must sell its license. City: Washington, D.C. State: Washington, D.C. Read More Jul 14, 2025 Marijuana Moment Federal Agency Cancels Marijuana Production Deal With University Of Mississippi, Ending Partnership That Lasted Half A Century The National Institute on Drug Abuse (NIDA) has ended its partnership with the University of Mississippi for cannabis production, though the university's federal contract for cannabis research continues until 2028. This comes after the Department of Government Efficiency (DOGE) also ended a contract with Ole Miss for monitoring cannabinoid content. Despite these cancellations, the University of Mississippi will continue its marijuana research through various centers and partnerships, including a new NIH-hosted resource center. The article also notes the expansion of DEA-approved cannabis growers for research and ongoing challenges in studying marijuana due to its Schedule I classification. City: NA State: Mississippi, Washington, D.C. Read More Jul 14, 2025 Outlaw Report D.C. shuts down second magic mushroom shop in ongoing crackdown Cap & Stem, a D.C. mushroom dispensary, was closed by ABCA and MPD, making it the second such closure in the past year as officials target unlicensed psychedelic businesses. City: Washington, D.C. State: Washington, D.C. Read More Jul 8, 2025 Marijuana Moment 9 In 10 Americans Support Legalizing Marijuana... 9 In 10 Americans Support Legalizing Marijuana In Some Form, Including Bipartisan Majorities, Pew Poll Shows City: NA State: Washington, D.C., Florida Read More Jul 8, 2025 MJbizDaily District of Columbia medical marijuana sales soar, but many dispensaries are struggling Medical marijuana sales in Washington, D.C., have almost doubled since January, but many dispensaries that converted from "gifting" shops are facing significant struggles. City: Washington, D.C. State: Washington, D.C. Read More Jul 8, 2025 Outlaw Report Cookies weed brand officially lands this week in D.C. Cookies, a globally recognized cannabis brand, will open its East Coast flagship store in Washington D.C. on July 11 at 4:20 PM, located at 1115 U Street NW. This marks a significant development for D.C.'s cannabis market as it is the first national brand to collaborate with local businesses to release products legally. City: Washington, D.C. State: Washington, D.C. Read More Jul 3, 2025 Marijuana Moment Marijuana’s Schedule I Status ‘Traps Researchers In A Paradox,’ Federally Funded Scientists Say Researchers involved in a federally funded clinical trial on marijuana highlight the critical importance of further study into the substance, given its widespread use. They argue that classifying cannabis as a Schedule I substance creates a paradox, as it heavily restricts the very studies needed to prove its medical value. The researchers advocate for moving marijuana to Schedule III to ease restrictions, increase NIH funding, and improve access to government-approved cannabis supplies. They also point out obstacles such as systemic underfunding, institutional hesitancy due to stigma, navigating multiple federal agencies, and limited supply of NIDA-approved marijuana. The article emphasizes that reform is crucial to close the evidence gap and address public health concerns. City: NA State: Maryland, Washington, D.C. Read More Jul 3, 2025 Marijuana Moment Lawsuit Claims Marijuana Questions In Federal Security Clearance Process Violated DOD Contractor’s Constitutional Rights A U.S. Department of Defense (DOD) contractor is suing the federal government, alleging that questions about his past marijuana use during a security clearance process violated his Fifth Amendment right against self-incrimination. The lawsuit, filed by Robert Filipiuk, an aerospace engineer, claims that he was forced to choose between self-incrimination and losing his security clearance and employment. The case highlights broader legal questions about federal workers and marijuana use, especially as more states legalize the drug. The article also touches on issues in the trucking industry regarding marijuana testing and the lack of technology to detect impaired driving. City: NA State: Washington, D.C. Read More Jul 2, 2025 Outlaw Report DC Xtracts emphasizes craft extraction and brand integrity, while the D.C. market sees soaring delivery sales amidst increased retail competition Summary: D.C., Virginia and Maryland cannabis news from June 25 to July 1, 2025. City: Washington, D.C. State: Washington, D.C., Virginia, Maryland Read More Jul 1, 2025 Outlaw Report Inside DC Xtracts: Rob Vasquez on Craft Cannabis Extraction and Brand Integrity DC Xtracts, founded by Rob Vasquez, has gained a loyal following in Washington D.C.'s medical cannabis program by producing clean and honest extracts that reflect the quality of the flower, setting them apart from other companies in the market. City: Washington, D.C. State: Washington, D.C. Read More Jul 1, 2025 MG Magazine Top CRMs for Cannabis Businesses A CRM system is crucial for businesses to track customer interactions, streamline communication, and enhance customer engagement to drive sales and revenue. For the cannabis industry, finding a CRM that meets its unique compliance needs has historically been a challenge, but by 2025, more tailored solutions are available. While mainstream CRMs like Salesforce and HubSpot are options for larger companies, many cannabis-specific solutions offer deep integrations with POS systems, compliance tools, and loyalty programs. Key CRM features for dispensaries include POS integration, centralized customer data, built-in loyalty programs, marketing automation, compliance tools, and analytics. The article lists 12 CRM providers, including IndicaOnline, Distru, Outfield, Springbig, AIQ Ecommerce, Zoho, 365 Cannabis, Meadow, Apex Trading, HubSpot, Salesforce, and Pipedrive, highlighting their target markets (B2B/B2C), cost information, and integration capabilities. The article concludes by answering common questions about cannabis-friendly CRMs, their importance for dispensaries, key features, and whether mainstream CRMs are suitable for the industry. City: NA State: California, Massachusetts, Michigan, New Jersey, New York, Washington, D.C. Read More Jul 1, 2025 Marijuana Moment Nebraska Governor Approves Medical Marijuana Rules Banning Flower Access For Patients Nebraska Gov. Jim Pillen has approved emergency rules for licensing medical cannabis establishments, with licensing to begin by October 1. The regulations were imposed by voters last November, legalizing medical cannabis with a healthcare practitioner's recommendation. The Nebraska Medical Cannabis Commission will regulate the new medicine. The rules set criteria for licenses (cultivator, manufacturer, dispensary, transporter), including ownership, fingerprinting, location restrictions, and prohibited persons. Dispensaries are limited to one per judicial district and can sell specific products like oral tablets, tinctures, gels, and patches, but not raw plant, edibles, or products for smoking/vaping. Public feedback on the emergency regulations is open until July 15. Advocates have expressed concerns about the ban on whole-plant cannabis and restrictions on usage methods. Formal regulations are expected to follow the emergency guidelines. City: NA State: Nebraska, Virginia, Washington, D.C. Read More Jun 30, 2025 Leafly Anacostia Organics: Cannabis with care in the capital Anacostia Organics, established in 2019, was the first medical dispensary to open east of the Anacostia River in Washington, D.C. City: Washington, D.C. State: Washington, D.C. Read More Jun 30, 2025 MG Magazine Jones Soda to Keep Hemp Product Line After Divesting Marijuana Division Jones Soda Co. has sold its marijuana-derived THC business but will continue to focus on its fast-growing hemp-derived THC product line, which includes Mary Jones sodas, shooters, and gummies. The company aims to accelerate investment in its core soda, functional beverage, and adult beverage categories, including the hemp-infused THC segment. Jones Soda Co. is a craft beverage company headquartered in Seattle, Washington, known for its premium sodas and adult beverages. City: Seattle State: Washington, D.C. Read More Jun 30, 2025 Outlaw Report D.C. cannabis market sees delivery sales soar amidst retail competition D.C. resident patients are the primary contributors to delivery sales, but self-certified temporary non-D.C. resident patients are showing significant growth in this area. All patient categories saw an increase in delivery sales. City: Washington, D.C. State: Washington, D.C. Read More Jun 24, 2025 Outlaw Report Out-of-State patients closing in on half of the D.C. cannabis market The cannabis market in Washington, D.C. is changing, with more out-of-state patients, particularly due to the city's self-certification. Although D.C. residents still make up most of the buyers in May 2025, out-of-state shoppers are increasing. City: Washington, D.C. State: Washington, D.C. Read More Jun 20, 2025 Ganjapreneur Maryland Governor Issues 7,000 Cannabis Pardons Maryland Gov. Wes Moore (D) announced pardons for nearly 7,000 people convicted of cannabis crimes. This follows a previous pardoning of over 175,000 past cannabis convictions. Moore also announced investments for underserved neighborhoods, historically Black universities and colleges, and procurement contracts for Black-owned businesses. The governor's pardons forgive past convictions but do not expunge them. A bill was signed into law to automatically shield low-level cannabis convictions from public view. Maryland's adult-use cannabis market launched in 2023. City: Washington, D.C. State: Washington, D.C., Maryland Read More Jun 18, 2025 Marijuana Moment Texas Military Veterans Say Potential Ban On Hemp-Derived THC Could Drive Them Back To Opioids Or The Illicit Marijuana Market Texas veterans with chronic pain are concerned that a potential ban on hemp-derived THC products could force them to return to opioids or the illicit marijuana market. The ban is part of a bill that would prohibit the possession of consumable hemp products containing any synthetic cannabinoid. Some veterans are concerned about the high cost, dosing inflexibility, and civil rights issues raised by the legal alternative. City: New York, San Antonio, Washington, D.C. State: New York, Texas, District of Columbia, Colorado, Washington, D.C. Read More Jun 13, 2025 Marijuana Moment Congressional Committee Clarifies That Hemp Ban Isn’t Meant To Restrict ‘Industrial Or Nonintoxicating’ Products A powerful GOP-led congressional committee amended a report for a spending bill containing provisions that hemp stakeholders say would upend the industry, clarifying that the panel does not intend to prohibit non-intoxicating cannabinoid products with “trace or insignificant amounts of THC” that were federally legalized during the first Trump administration... City: NA State: Illinois, Kentucky, Maryland, Washington, D.C. Read More Jun 10, 2025 Outlaw Report Capitol Hemp sues D.C. over hemp laws and challenges congressional ban Capitol Hemp filed two lawsuits challenging hemp regulations and the Harris Amendment. City: Washington, D.C. State: Washington, D.C. Read More Jun 10, 2025 Outlaw Report D.C. considers “Craft Preparation” endorsement for medical cannabis retailers Washington D.C. is moving to expand options for medical cannabis patients with proposed legislation, the "Medical Cannabis Retailer Craft Preparation Endorsement Amendment Act of 2025." This act aims to create a new "craft preparation endorsement" allowing licensed medical cannabis retailers to prepare certain products on-site. Source City: Washington, D.C. State: Washington, D.C. Read More Jun 9, 2025 Outlaw Report Crafting Calm in a Fast-Paced World: The Story Behind Easyday Edibles We chatted with Alan Manstof about his path to launching Easyday Edibles. What began with a stove-top gummy experiment evolved into a brand defined by clean ingredients and a laid-back ethos. In this interview, Manstof reflects on building a cannabis edibles brand, why every gummy deserves to be beautiful, and how his “analog place” became a guiding philosophy for the business. Source City: Washington, D.C. State: Washington, D.C. Read More Jun 4, 2025 Ganjapreneur Study: Cannabis Use Among Older Adults Higher Than Ever Older Americans are using cannabis at record levels. Cannabis use among those 65+ jumped over 40% from 2021 to 2023. Increased cannabis use was most prevalent among women, white people, people with a degree, people making $75,000+ per year, married people, and people who live in a state with legal medical cannabis access. Cannabis use was also more prevalent among those with serious and chronic health conditions. City: Washington, D.C. State: Washington, D.C. Read More Jun 2, 2025 Outlaw Report D.C. cannabis tax revenue soars but unlikely to trickle down to equity fund D.C. medical cannabis sales surged to $5.46 million in April 2025, generating a 90% increase in tax revenue compared to the previous year, yet cannabis remains one of the city's lowest-taxed goods at 6%. City: Washington, D.C. State: Washington, D.C. Read More May 27, 2025 Ganjapreneur Washington to Issue New Social Equity Cannabis Licenses This Summer The Washington Cannabis Social Equity Program will begin accepting applications for 52 new retail social equity licenses this June. The licensing period will be open from June 2 to July 1. Qualifying applicants must meet at least two of the social equity program’s four licensing criteria. City: Washington, D.C. State: Washington, D.C. Read More May 14, 2025 Cannabis Business Times Herbal Alternatives Dispensary Founder Pleads Guilty to $1.2 Million in Federal Tax Evasion The former owner of the Washington, D.C.-based cannabis retailer admitted to not paying federal income and employment taxes for five tax years. City: Washington, D.C. State: Washington, D.C. Read More May 14, 2025 MJ Biz Daily District of Columbia cannabis dispensary founder pleads guilty to tax evasion The founder of a medical cannabis dispensary in Washington, D.C., pleaded guilty to charges of failing to pay more than $1.2 million in federal income and employment taxes for five years. City: Washington, D.C. State: Washington, D.C. Read More May 12, 2025 Cannabis Now Film Review: Grassland Is A Stunner William Bermudez and Sam Friedman’s *Grassland* is a gripping social justice drama that transports viewers back to 2008, a year marked by the financial crisis and the height of America’s punitive War On Drugs. The film tells the story of how a Latina single mom, Sofia (Mía Maestro) grows cannabis in the basement of her rented apartment to make ends meet for her and her young son, Leo (Ravi Cabot-Conyers). Their lives take a dramatic turn when their new neighbor, John (Jeff Kober), a retired cop, moves into the building and his grandson befriends Leo. Tension escalates as John’s suspicions about Sofia’s activities grow, threatening to unravel her precarious world. Cabot-Conyers delivers an endearing performance as Leo, whose wide-eyed innocence provides a stark contrast to the harsh realities of his life. Meanwhile, Kober plays John with depth; his character is shaped by his own biases and regrets, making him both antagonist and victim of systemic failure while raising his grandson Tom alone. Sofia’s story feels real and raw. She’s not portrayed as a criminal, but as a mother doing what she must to care for her child during rough times. Maestro’s performance captures Sofia’s struggles perfectly, showing her strength and vulnerability. Her basement grow operation isn’t glamorous—it’s a lifeline—and yet it puts her at risk in a society that punished people harshly for even small amounts of cannabis. The film also highlights how unfairly cannabis laws were enforced almost two decades ago. In 2008, Black and Latino communities were disproportionately targeted the most, facing much higher arrest rates than white people for marijuana possession. These disparities are embodied in Brandon (Quincy Isaiah), Sofia’s friend who helps care for Leo but avoids deeper involvement in her operation due to his own criminal record—a chilling reminder of how even minor offenses can derail lives. *Grassland* is more than a film about cannabis; it’s about survival, injustice and the real painful human cost of systemic racial profiling. What makes *Grassland* hit home today is how much has changed—and how far we still must go. Cannabis legalization has spread across the US, with 24 states and Washington, DC, legalizing adult use. Main Street dispensaries sell products legally that once sent people to prison (and still do in some states). Yet, thousands are still locked up for non-violent cannabis-related convictions, some serving long sentences for small amounts of weed. Groups such as Freedom Grow, 40 Tons and the Last Prisoner Project are working to free these individuals, but progress is slow. Society’s view of cannabis has changed dramatically since 2008. Back then, only about 30 percent of Americans supported legalization; now, according to a 2024 Pew research poll, 88 percent of US adults say cannabis should be legal for medical or adult use. It’s a booming industry, with the US market size estimated at $38.50 billion in 2024. Yet despite this cultural change, systemic barriers persist, particularly for those whose lives were upended by prohibition-era policies. *Grassland* reminds us that justice means more than changing laws. It means clearing records, freeing prisoners and helping those hurt by the War On Drugs rebuild their lives. Quincy Isaiah’s character Brandon, highlights the injustices and painful human cost of racial profiling by the police and others. *Grassland* never loses focus on its principal message: Cannabis prohibition ruined lives. Sofia’s story represents that of countless others who were punished for doing things that are now legal—even profitable. By revisiting the dark days of 2008 through Sofia’s eyes, the film challenges us to not only reflect on how far we’ve come, but also to acknowledge how much further we must go to right the wrongs of the past. With its thoughtful storytelling and nuanced performances, *Grassland* serves as both a time capsule of a broken system and a call to action for justice in the present day. For anyone interested in cannabis advocacy or social justice, this film is a must. It challenges us to think about what justice means, and how it remains elusive for so, so many. The post Film Review: Grassland Is A Stunner appeared first on Cannabis Now. City: Washington, D.C. State: Washington, D.C. Read More May 2, 2025 Ganjapreneur PreRoll Press Inc. Delivers Cutting-Edge Pre-Roll Manufacturing Solutions to Optimize Production PreRoll Press Inc. offers pre-roll manufacturing solutions to address challenges in the booming cannabis market, such as labor-intensive processes and inconsistent quality. Their systems optimize efficiency, reduce costs, and ensure high-quality pre-rolls, including the Fill N' Fold system with a Dutch Crown finish. They offer scalable systems for various production capacities and stand out with innovative solutions for infused pre-rolls, cost-effective equipment, and user-friendly design. Early adopters have reported significant improvements in labor and product consistency. PreRoll Press aims to empower producers and shape the future of cannabis production. City: Washington, D.C. State: Washington, D.C. Read More Apr 26, 2025 Ganjapreneur Trump DOJ Attorney Sends Warning Letter to Licensed D.C. Dispensary *Editor’s note: this article was originally published by The Outlaw Report and has been republished with permission.* U.S. Attorney for the District of Columbia Edward R. Martin Jr. has issued a letter to Green Theory, a licensed cannabis dispensary located at 4828 MacArthur Blvd., NW, expressing concern that its operation violates federal law due to its proximity to several area schools... City: Washington, D.C. State: Washington, D.C. Read More Feb 3, 2025 Dope CFO Cannabis Rescheduling in 2025: Expert Insights on Federal Policy Changes The Cannabis industry stands at a pivotal crossroads in 2025. With federal rescheduling proceedings facing unexpected delays and a new administration settling into office, Cannabis businesses and their accountants face significant uncertainty about the regulatory landscape ahead. Understanding these complex policy developments is essential for Cannabis businesses to navigate compliance requirements and prepare for potential changes that could dramatically impact their operations and tax obligations. In this comprehensive analysis, we explore the current state of Cannabis rescheduling efforts, examine the political dynamics at play in Washington, and provide strategic guidance for Cannabis businesses and their financial advisors during this transitional period. The Long Road to Rescheduling: How We Got Here Since the passage of the Controlled Substances Act in 1970, Cannabis has been classified as a Schedule I substance—a category reserved for drugs with "no accepted medical use" and "high potential for abuse." This classification has placed Cannabis in the same category as heroin and LSD, despite mounting scientific evidence of its medicinal benefits and moderate risk profile. City: Washington, D.C. State: Washington, D.C. Read More Dec 19, 2024 Cannabis Now MJBizCon 2024 Highlights Resilience and Growth in Cannabis The 11th annual MJBizCon welcomed cannabis industry professionals. There was a lot to see with 1400 exhibitors. The energy on the show floor was palpable, with deals being made and connections solidified. A spirit of collaboration was also in the air. Events included The Vegas Classic, Blunt Brunch Nationals, and The Emjays. Several brands caught the eye, including Zamnesia, Royal Queen Seeds, FOHSE, Advanced Nutrients, CCELL, and My Bud Vase. City: Las Vegas, Seattle State: Nevada, Washington, D.C. Read More Dec 9, 2024 Cannabis Now Stretch Further: Jessamyn Stanley Redefines Wellness Culture In an article, Jessamyn Stanley discusses her use of cannabis, and how she has incorporated it into her yoga practice. Stanley, who identifies as fat, black, and queer, discusses the stigma surrounding marijuana, and how the forces of white, corporate control are especially insidious in the cannabis industry. City: New York, Seattle State: New York, North Carolina, Washington, D.C. Read More

Shop Top Cannabis Products Product Category Filter items with Service Type Delivery Direct Shipping Download Pick-up Filter by Effects Select Effects Filter by Brand Select Brand Filter by Location Select Location Runtz (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $30.00 Order 4.5 115 Ratings average rating is 4.5 out of 5, based on 115 votes, Ratings Zkittlez (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $30.00 Order 4.6 137 Ratings average rating is 4.6 out of 5, based on 137 votes, Ratings Bubba Kush (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.6 130 Ratings average rating is 4.6 out of 5, based on 130 votes, Ratings Sour Diesel (Sativa) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 151 Ratings average rating is 4.7 out of 5, based on 151 votes, Ratings GMO Cookies (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 142 Ratings average rating is 4.7 out of 5, based on 142 votes, Ratings Forum Cookie (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.8 168 Ratings average rating is 4.8 out of 5, based on 168 votes, Ratings Wedding Cake (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $30.00 Order 4.6 123 Ratings average rating is 4.6 out of 5, based on 123 votes, Ratings CBD Live Resin Blend (CBG-Boosted) by Tribe Tokes - Gummies | Lemon Flavor $38.00 Order 4.7 138 Ratings average rating is 4.7 out of 5, based on 138 votes, Ratings The TribeMINI Vape Battery by Tribe Tokes | Palm-Sized, Discreet $45.00 Order 4.6 106 Ratings average rating is 4.6 out of 5, based on 106 votes, Ratings Saber 'Car Key' Vape Battery by Tribe Tokes | Foldable, Discreet $50.00 Order 4.5 91 Ratings average rating is 4.5 out of 5, based on 91 votes, Ratings Tropicanna Cherry (Sativa) by Tribe Tokes - THCA Flower | Premium Indoor 8th (3.5g) $45.00 Order 4.6 148 Ratings average rating is 4.6 out of 5, based on 148 votes, Ratings CBN Live Resin Blend (CBD-Boosted) by Tribe Tokes - Gummies | Peach Flavor $38.00 Order 4.8 154 Ratings average rating is 4.8 out of 5, based on 154 votes, Ratings THC Buzzed Blend (Delta 8-Boosted) by Tribe Tokes - Gummies | Pineapple Flavor $40.00 Order 4.6 122 Ratings average rating is 4.6 out of 5, based on 122 votes, Ratings Delta 8 Bears (CBD-Boosted) by Tribe Tokes - Gummies | Mixed Berry Flavor $35.00 Order 4.5 94 Ratings average rating is 4.5 out of 5, based on 94 votes, Ratings CBD Bears (THC-Free, CBG-Boosted) by Tribe Tokes - Gummies | Mixed Berry Flavor $35.00 Order 4.8 145 Ratings average rating is 4.8 out of 5, based on 145 votes, Ratings Downloadable Files Coming Soon NA Order No ratings yet Cookie Chip (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 147 Ratings average rating is 4.7 out of 5, based on 147 votes, Ratings Northern Lights (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 144 Ratings average rating is 4.7 out of 5, based on 144 votes, Ratings Cheetah Piss (Sativa) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.8 172 Ratings average rating is 4.8 out of 5, based on 172 votes, Ratings Rainbow Sherbert (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 144 Ratings average rating is 4.7 out of 5, based on 144 votes, Ratings Lemon Haze (Sativa) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.8 169 Ratings average rating is 4.8 out of 5, based on 169 votes, Ratings Ice Cream Cake (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 151 Ratings average rating is 4.7 out of 5, based on 151 votes, Ratings Apple Fritter (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.6 134 Ratings average rating is 4.6 out of 5, based on 134 votes, Ratings THC Libido Lift Blend (CBC-Boosted) by Tribe Tokes - Gummies | Peach Flavor $40.00 Order 4.6 112 Ratings average rating is 4.6 out of 5, based on 112 votes, Ratings Blue Dream (Hybrid) by Tribe Tokes - THCA Flower | Premium Indoor 8th (3.5g) $45.00 Order 4.5 132 Ratings average rating is 4.5 out of 5, based on 132 votes, Ratings CBD Full Gram Carts by Tribe Tokes | CBG-Boosted, 12 Strains $60.00 Order 4.7 133 Ratings average rating is 4.7 out of 5, based on 133 votes, Ratings THC Live Resin Blend (CBD-Boosted) by Tribe Tokes - Gummies | Mango Flavor $42.00 Order 4.6 115 Ratings average rating is 4.6 out of 5, based on 115 votes, Ratings CBD/CBN Sleep Blend by Tribe Tokes - Gummies | Peach Flavor $38.00 Order 4.8 161 Ratings average rating is 4.8 out of 5, based on 161 votes, Ratings Delta 8 Live Resin Blend (CBD-Boosted) by Tribe Tokes - Gummies | Strawberry Flavor $40.00 Order 4.7 126 Ratings average rating is 4.7 out of 5, based on 126 votes, Ratings Jealousy (Indica) by Tribe Tokes - THCA Flower | Premium Indoor 8th (3.5g) $45.00 Order 4.5 163 Ratings average rating is 4.5 out of 5, based on 163 votes, Ratings THC Everyday Blend (CBD + CBG Boosted) by Tribe Tokes - Gummies | Tangerine Flavor $40.00 Order 4.5 102 Ratings average rating is 4.5 out of 5, based on 102 votes, Ratings Nearby Delivery Coming Soon NA Order No ratings yet White Truffle (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 160 Ratings average rating is 4.7 out of 5, based on 160 votes, Ratings Lemon Cherry Gelato (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 156 Ratings average rating is 4.7 out of 5, based on 156 votes, Ratings Georgia Pie (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $30.00 Order 4.5 110 Ratings average rating is 4.5 out of 5, based on 110 votes, Ratings Gush Mintz (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $30.00 Order 4.6 124 Ratings average rating is 4.6 out of 5, based on 124 votes, Ratings Granddaddy Purple (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.6 136 Ratings average rating is 4.6 out of 5, based on 136 votes, Ratings Triangle Kush Cake (Indica) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $30.00 Order 4.6 122 Ratings average rating is 4.6 out of 5, based on 122 votes, Ratings White Widow (Hybrid) by Premium Cultivars - THCA Flower | Premium Indoor 8th (3.5g) $40.00 Order 4.7 149 Ratings average rating is 4.7 out of 5, based on 149 votes, Ratings Delta 8 THC Disposable Vape Pens by Tribe Tokes | Full Spectrum $60.00 Order 4.6 114 Ratings average rating is 4.6 out of 5, based on 114 votes, Ratings HHC Disposable Vape Pen by Tribe Tokes | Full Spectrum Blend $60.00 Order 4.7 129 Ratings average rating is 4.7 out of 5, based on 129 votes, Ratings The Wand Adjustable Voltage Vape Pen by Tribe Tokes | Battery Only $40.00 Order 4.4 83 Ratings average rating is 4.4 out of 5, based on 83 votes, Ratings Live Resin CBD Disposable Vape Pen by Tribe Tokes | 1.0 mL, Full Spectrum $60.00 Order 4.6 110 Ratings average rating is 4.6 out of 5, based on 110 votes, Ratings THC Sleep Blend (CBN-Boosted) by Tribe Tokes - Gummies | Mixed Berry Flavor $42.00 Order 4.7 143 Ratings average rating is 4.7 out of 5, based on 143 votes, Ratings 1:1 Ratio Vape Pen by Tribe Tokes | Half CBD, Half D8 THC $60.00 Order 4.6 105 Ratings average rating is 4.6 out of 5, based on 105 votes, Ratings CBD Libido Lift Blend (CBC-Boosted) by Tribe Tokes - Gummies | Cherry Flavor $38.00 Order 4.7 137 Ratings average rating is 4.7 out of 5, based on 137 votes, Ratings THCa Disposables by Tribe Tokes | Live Resin Vape Pens $60.00 Order 4.8 167 Ratings average rating is 4.8 out of 5, based on 167 votes, Ratings Nearby Pick-up Coming Soon NA Order No ratings yet